Up next

Autoplay

PLATO and immunotherapy trials in anal cancer

3 Views • 03/09/25
Share
Embed
administrator
administrator
Subscribers
0

David Sebag-Montefiore, MRCP, FRCR, Leeds Teaching Hospitals NHS Trust, Leeds, UK, talks about two different trials with strategies for improving outcomes from anal cancer treatment; amending dosage of radiotherapy (PLATO; ISRCTN88455282) and novel agent combinations (CORINTH; NCT04046133). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay